On 24 April, a delegation from Diaverum led by the company’s CEO, Mr. Dimitris Moulavasilis, met with Nipro’s President, Mr. Yoshihiko Sano, at the new Nipro Corporation Japan headquarters in Osaka, Japan, to mark the signing and official commencement of a prolonged partnership between the parties.
Diaverum and Nipro are committed to further strengthening ties and exploring long-term opportunities for continued and diversified collaboration in many areas, reinforcing Nipro’s role as a strategic partner of Diaverum. The concept of “Value-Based-Care” resonates with both companies, who share the ultimate goal of delivering the best possible patient outcomes by providing efficient, holistic, and adequate treatment solutions.
Dimitris Moulavasilis, Diaverum CEO, said: “We value Nipro as a strategic partner for its comprehensive portfolio, good logistics, and extensive field presence globally. This long-term and wider scope partnership with Nipro will strengthen our ability to manage inflationary pressures and enjoy efficiencies in strategic areas, ultimately benefiting patients and healthcare systems worldwide”.
Yoshihiko Sano, Nipro President, said: “We have been working with Diaverum since 2008, supporting the healthcare organisation with high-value products and reliable customer service. As well as an extension of the partnership, the number and types of products that would be supplied have also expanded.”
Nipro Medical Europe is part of Nipro Corporation Japan, a leading global healthcare company established in 1954. With over 35,000 employees worldwide, Nipro serves the Medical Device, Pharmaceutical, and Pharmaceutical Packaging industries.